Randomized double-blind trial assesses phospholipid curcumin effects on liver histology and kidney disease in nonalcoholic steatohepatitis, highlighting targeted delivery strategies.
NASH confers an increased liver-related and kidney morbidity. Phospholipid curcumin (Meriva) is a phospholipid formulation with ameliorated systemic curcumin absorption and delivery. We assessed the safety and efficacy of Meriva in NASH.
No takes yet. Share an insight, caveat, or question.
Musso et al. (2024) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: